Clinical Trials Browser

Phase 1 × Withdrawn × Gynecologic × Clear all

NCT06626256 2025-12-24

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Phase 1 Withdrawn

DermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06681870 2025-01-15

A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

Phase 1 Withdrawn

GenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms

NCT06161493 2024-10-15

ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors

Phase 1 Withdrawn

Ovarian Neoplasms

NCT05826015 2024-10-02

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Phase 1 Withdrawn

Recurrent High Grade Uterine Cancer

NCT05655598 2024-09-19

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Phase 1 Withdrawn

GenitourinaryGynecologicSarcoma

Urinary Bladder Neoplasms, Sarcoma, Endometrial Neoplasms

NCT06216561 2024-08-20

Intraperitoneal LSTA1 in CRS-HIPEC

Phase 1 Withdrawn

GastrointestinalGynecologic

Appendiceal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT04542603 2024-04-25

Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms

NCT04602117 2023-11-18

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Phase 1 Withdrawn

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05905341 2023-11-08

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Phase 1 Withdrawn

BreastGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Ovarian Neoplasms

NCT05431582 2023-06-15

Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors

Phase 1 Withdrawn

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT04149145 2023-06-07

PARP

Phase 1 Withdrawn

Ovarian Neoplasms

NCT05393635 2022-12-20

DELTA-2

Phase 1 Withdrawn

GynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms

NCT02117817 2022-07-28

Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms, Endometrial Neoplasms

NCT04941378 2022-06-27

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms

NCT03682744 2022-04-06

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Phase 1 Withdrawn

BreastGastrointestinalGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04611139 2022-03-02

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

Phase 1 Withdrawn

Endometrial Neoplasms

NCT03400306 2021-12-08

A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms

NCT04498520 2021-05-18

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Phase 1 Withdrawn

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Carcinoma, Endometrioid

NCT04411134 2020-07-15

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

Phase 1 Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03644459 2020-03-11

Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101

Phase 1 Withdrawn

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02050009 2019-02-20

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Withdrawn

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02277392 2018-09-27

A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 1 Withdrawn

Ovarian, Fallopian Tube and Peritoneal Cancer

NCT02833506 2018-05-01

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00428194 2017-11-29

Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms

NCT03007771 2017-10-06

Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia

Phase 1 Withdrawn

GastrointestinalGenitourinaryGynecologicSarcoma

Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Sarcoma

NCT01386502 2017-07-02

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Phase 1 Withdrawn

BreastGastrointestinalGynecologicSarcoma

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT02567396 2017-04-24

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Phase 1 Withdrawn

BreastGastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01138137 2017-04-21

N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

Phase 1 Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00842582 2016-11-02

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms

NCT02083536 2016-08-10

LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Phase 1 Withdrawn

Ovarian Neoplasms

NCT00503919 2016-04-08

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device

Phase 1 Withdrawn

Uterine Cervical Dysplasia

NCT01514955 2016-02-25

IMRT

Phase 1 Withdrawn

Integrated MRI Based RT as Standard of Care

NCT02470559 2016-02-17

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Phase 1 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00659399 2015-03-18

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Phase 1 Withdrawn

Ovarian Neoplasms

NCT02312804 2015-02-16

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Phase 1 Withdrawn

Uterine Cervical Neoplasms, Neoplasms

NCT00967928 2014-02-14

Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms

NCT00017537 2013-08-05

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Phase 1 Withdrawn

BreastGastrointestinalGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT00942838 2013-07-24

WAR

Phase 1 Withdrawn

Neoplasms, Ovarian Neoplasms

NCT00137358 2013-01-24

Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms, Neoplasms

NCT00118300 2011-07-08

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Phase 1 Withdrawn

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT01000896 2010-02-04

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Phase 1 Withdrawn

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Neoplasms